Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950123-04-012977
Filing Date
2004-11-04
Accepted
2004-11-04 07:43:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 e68336a1sv3za.htm S-3/A 615086
2 CONSENT OF KPMG LLP e68336a1exv23w1.txt EX-23.1 1491
3 GRAPHIC e68336a1e6833600.gif GRAPHIC 2338
4 GRAPHIC e68336a1e6833601.gif GRAPHIC 2428
  Complete submission text file 0000950123-04-012977.txt   623342
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3/A | Act: 33 | File No.: 333-119229 | Film No.: 041117959
SIC: 2835 In Vitro & In Vivo Diagnostic Substances